Clinical Trials and SPA Fall, 2014
|
|
- Hilary Perry
- 8 years ago
- Views:
Transcription
1 Clinical Trials and SPA Fall, 2014 Laura Williams Frances Spalding Sponsored Projects Administration
2 What to Expect Review of key clinical trial concepts A common clinical trial process How SPA fits in the picture Processing delays and other things to consider Final review and steps Resources
3 Did you know?
4 CTSI Hub Pilot Project On Jan. 17, 2013, the U of M launched a pilot project designed to streamline start up, management and oversight of industry-sponsored clinical trials. The project a collaborative effort of the Academic Health Center (AHC), the Office of the Vice President for Research (OVPR), the Controller s Office, Fairview Health Services, and University of Minnesota Physicians (UMP) has the potential to make a significant contribution to the university s ongoing operational excellence efforts. For more information check:
5 CTSI Hub In January, 2014, at the expiration of the pilot, the CTSI Hub launched. The CTSI is part of the AHC, and is supported through the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grant UL1TR It is one of approximately 60 CTSA research institutions nationwide. BMHI, one division of CTSI, is responsible for CTMS OnCore Implementation. Phased roll out has begun, and Pediatrics, Oncology and Cardiovascular are using the full enterprise versions of CTMS. CTMS support also housed in CTSI Consolidation is ongoing and expected to broaden
6 What is a Clinical Trial? How is it different than Research? Clinical Trial: A research study to test drugs, procedures or testing technologies to determine whether these are effective and/or safe. Research: A systematic, intensive study intended to increase knowledge or understanding of the subject studied.
7 Why faculty would consider clinical research? Opportunity to do good science that helps people For an individual principal investigator it provides the possibility to approach science with a new type of research
8 Definition of the term, sponsor in clinical trial research When you see the term sponsor be aware of the definition of the role: Regulatory sponsor FDA responsible entity Financial sponsor Entity that provides the money for the trial
9 How to locate a clinical trial? Check with colleagues now working on a study who might know of other possibilities. Locate and speak with a company s monitor who works with like studies PI might be interested partnering with. Check with This FDA website lists all existing and planned clinical trials
10 Clinical Trial Sponsor usually fall under one of these categories? A governmental organization A pharmaceutical company A bio-technology company
11 Most clinical trials have common elements Depending on the type of product and the stage of its development, investigators: 1. Enroll healthy volunteers and/or patients into small pilot studies initially 2. Followed by larger scale studies in diagnosed patients that often compare the new product with the currently prescribed treatment
12 A common clinical trial During the clinical trial, the investigators: 1. Recruit patients with the predetermined characteristics 2. Administer the treatment(s) 3. Collect data on the patients' health for a defined time period
13 A successful clinical trial includes some key elements Protocol Investigator Brochure
14 What is a clinical trial protocol? It describes the scientific rationale, objective(s), design, methodology, statistical considerations, and organization of the planned trial. It contains a precise study plan for executing the clinical trial, not only to assure safety and health of the trial subjects, but also to provide an exact template for trial conduct by investigators.
15 Another common element is an investigator brochure An Investigator Brochure is intended to provide the PI with the knowledge necessary for management of study conduct and study subjects throughout a clinical trial.
16 Investigator s Brochure includes A brief description of the drug substance and formulation A summary of the pharmacological and toxicological effects of the drug A summary of the information relating to safety and effectiveness from prior studies. A description of known side effects.
17 So what is the process? The company sends the brochure and protocol to the PI. The PI reviews the information and decides to participate. PI works with University to set up the clinical trial.
18 At the U of Minnesota There are at any one time 400 active clinical trials. Budgets B&I sponsors are calculated at a 26% Total Direct Cost base Budgets for Federal Sponsors are calculated at a 52% Modified Total Direct Cost base
19 So how does all this information translate to the University of Minnesota? The PRF and supporting documentation are collected and submitted to SPA in two stages: An initial stage that allows for negotiation while documentation is being fine tuned A final stage where the final documentation is submitted and an agreement is in place
20 Industry Sponsored Clinical Trials follow an Expedited Review process for PRFs The Expedited Review assists the PI by reducing the time needed to process the clinical trial contract. Check the SPA webpage at: edures/b&iclinicaltrials.html
21 First step of the Expedited PRF The PRF is prepared but signed only by the principal investigator (PI), then delivered to SPA with the contract, simple budget, and protocol. SPA will initiate the review/negotiation process within two weeks of receipt the initial documents.
22 Preaward If work begins and expenses are incurred before the contract is finalized, the PI must complete and forward a Preaward/Advanced Account Request form to SPA: along with a fully signed PRF explaining to SPA why a pre-award account is being requested. An example of a pre-award cost is the IRB $2500 fee along with the associated IDC.
23 The budget for the clinical trial is developed Review the study protocol Separate the research from the standard care Define personnel roles, personnel time needed and hourly cost Estimate costs for studies/procedures Any misc. costs that might not be obvious at first glance?
24 A resource for University faculty is CTSI? CTSI stands for Clinical and Translational Science Institute. The mission of CTSI is to improve the health of our communities through collaborative clinical and translational research. Webpage:
25 CTSI provides a wide range of clinical research services Consultation on CTSI resources Grant preparation Statistical collaboration and consultation Regulatory assistance (FDA, IRB applications; clinical trial monitoring) Study audit (record and reporting) Protocol writing IND/IDE submission ( IAP )
26 U of MN compliance issues need to be considered is a link provided by the OVPR which can help guide you with policy that may be applicable to the clinical trial being considered.
27 Something else to be aware of All clinical research projects requesting services from the University of Minnesota Physicians (UMP) and/or Fairview will be required to conform to the Clinical Research Budgeting and Billing policy: It is essential that the PI determine early in the process which cost elements are standard care and which are research-specific. For each clinical research project, the PI must document the financial responsibility for paying for each service, drug, test or procedure.
28 TASCS= Time and Study Collection System Fairview s system to delineate the services, drugs, devices, tests, and procedures rendered for clinical research. Check TASCS webpage for information and resources: esearchaccountsandbilling/tascs/s_014082
29 Second step of this two part process for the SPA expedited review After negotiations on the protocol are completed and the budget is finalized, the PRF is retrieved and updated, submitted to the department and college for review and approval.
30 Submission to SPA Once approved by all individuals included on the PRF, a copy of the documents are delivered to SPA. Talk with your Grant Administrator on the best method of submission for the final step of the process.
31 Some delays that hold up processing clinical trials Publication clause Confidentiality clause Intellectual Property clause Office of the General Counsel review Patents & Technology input PI input
32 Master Agreements The University of Minnesota has in place approved Master Agreements that shorten the negotiation process and speeds processing.
33 Final Review before submitting SPA will not sign off on contracts until it receives the fully signed PRF, final protocol and budgets.
34 Something to consider There is a parallel path with the IRB approval process, (users do not need to fully complete IRB before sending it to SPA however an approved IRB will need to be in place before any human subject work can begin). The IRB fee is waived for investigator sponsored clinical trials.
35 Resources SPA and your Business and Industry representative, x Laura Williams, Frances Spalding, SPA training Coordinator, Other SPA classes can be found at: nd%20calendars/trainingschedule.html#descriptions
36 Check out: Free on-line classes on a variety of clinical trial topics
37 Did you know about SPECTRUM? SPECTRUM (Sponsored Projects Education Certification Training at the University of MN) has been developed and implemented by a cross section of the University research community. There are approximately 34 courses identified to be developed and delivered. SPECTRUM courses started being rolled out during FY10 and in FY11. As soon as enough core courses have been developed, plans for the implementation of the certification program will be announced. Check the Training Services webpage: for additional information.
Presenters: Beth Nunnally, Corey Graves, Marlys Trettel
Presenters: Beth Nunnally, Corey Graves, Marlys Trettel 02/17/2014 Beth Nunnally, Academic Health Center Associate Vice President & Chief Financial Officer Corey Graves, Research Administrator, Cardiovascular
More informationOffice of Clinical Research and the. Institute (CTSI) Patricia Emmanuel, MD
Office of Clinical Research and the Clinical and Translational Research Institute (CTSI) Patricia Emmanuel, MD Office of Clinical Research- Priorities Review processes for clinical study implementation,
More informationROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
More informationCenterWatch. volunteering. clinical trial. for a. www.centerwatch.com
volunteering for a clinical trial www.centerwatch.com :: about this pamphlet This pamphlet provides an overview of the clinical trials process and answers frequently asked questions that many potential
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationThe CTSA Program: Collaborative Innovation for Translational Research
The CTSA Program: Collaborative Innovation for Translational Research Petra Kaufmann, MD, MSc Director, Division of Clinical Innovation NCATS ADVISORY COUNCIL MEETING JUNE 18, 2015 Transforming the CTSA
More informationHow to Increase Site Productivity with a CTMS. Manage financials, meet timelines, increase compliance, and more...
How to Increase Site Productivity with a CTMS Manage financials, meet timelines, increase compliance, and more... By Introduction Clinical trials are essential to the development and safety of new drugs
More informationResearch Administration. Clinical Trial Administration Part I: Overview of Clinical Trial Management. (Presented November 12 th and 14 th 2013)
Research Administration Clinical Trial Administration Part I: Overview of Clinical Trial Management (Presented November 12 th and 14 th 2013) Objective Provide an overview of the clinical trials lifecycle
More informationClinical Trials: The Crux of Cancer Innovation
Clinical Trials: The Crux of Cancer Innovation Even as medical science is transforming cancer care, major deficiencies in the way cancer clinical trials are designed, carried out, regulated and funded
More informationEssential Documents for the Conduct of a Clinical Trial. Debra Dykhuis Associate Director RSO
Essential Documents for the Conduct of a Clinical Trial Debra Dykhuis Associate Director RSO Introduction Rationale for choosing this topic AHC movement toward setting GCP (Good Clinical Practice) guidelines
More informationAcademic health centers continue to assess,
Elaine Rubin, PhD, and Danielle Lazar, MA Little uniformity exists in structure or functions; models needed for future Academic health centers continue to assess, change, and improve clinical research
More informationMedical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11
Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies
More informationLaurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
More informationUniversity of Pittsburgh
I. Guideline Background Sponsored projects (grants, contracts, cooperative agreements, etc.) and gifts comprise a significant portion of the operating revenue of the University. Distinguishing between
More informationROLE OF THE RESEARCH COORDINATOR
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Data Collection
More informationQ&A Intellectual Property Policy
Q&A Intellectual Property Policy Table of Contents Q: Why have an Intellectual Property Policy?... 3 Q: Does the IP Policy apply to me?... 3 Q: I am primarily affiliated with another institution and am
More informationDetermining who the investigators are and who the principal investigator is:
Responsibilities of the IRBs of the Health System and University for Research Conducted by Investigators from a Combination of the Following Institutions: the Health System, University, and Medical School
More informationThe Clinical Trials Office: Understanding Organizational Structure, Functions through a Real-World Lens
The Clinical Trials Office: Understanding Organizational Structure, Functions through a Real-World Lens August 27 th 2015 YOUR MISSION OUR SOLUTIONS Huron Consulting Group Inc. All Rights Reserved. Huron
More informationChristopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration
Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationClinical Trials Management System (CTMS) Overview
Clinical Trials Management System (CTMS) Overview 8.DEC.2011 Biomedical Informatics Core (BIC) Retreat Elizabeth Micalizzi, Director, Communications and Integrated Technology, Research Affairs and VCU
More informationPage 191 TITLE 21 FOOD AND DRUGS 355 1
Page 191 TITLE 21 FOOD AND DRUGS 355 1 APPEALS TAKEN PRIOR TO OCTOBER 10, 1962 Section 104(d)(3) of Pub. L. 87 781 made amendments to subsec. (h) of this section inapplicable to any appeal taken prior
More informationApplications are accepted on a rolling basis.
The University of Michigan Health System Peking University Health Science Center Joint Institute for Translational and Clinical Research Clinical Trial Grant Processes Purpose The University of Michigan
More informationGAO NEW DRUG DEVELOPMENT. Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering Drug Development Efforts
GAO United States Government Accountability Office Report to Congressional Requesters November 2006 NEW DRUG DEVELOPMENT Science, Business, Regulatory, and Intellectual Property Issues Cited as Hampering
More informationOECD Recommendation on the Governance of Clinical Trials
OECD Recommendation on the Governance of Clinical Trials Marketing authorisation status of the medicinal products Non-authorised medicine Authorised medicine, treatment regimen outside
More informationA clinical research organization
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
More informationCheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio Cherylkb@fuse.net
Cheryl K. Bernstein RN, BSN, CCRC Director Bernstein Clinical Research Center, LLC Cincinnati, Ohio Cherylkb@fuse.net Identify and discuss the language used in reciprocal or crossed indemnification and
More informationWHEN I WANT TO: I NEED TO SUBMIT: {for CIRB studies, see the specific FAQ}
IRB forms and materials to be submitted WHEN I WANT TO: I NEED TO SUBMIT: {for CIRB studies, see the specific FAQ} 1 2 Request a determination as to whether AHC is the appropriate IRB of record (i.e. is
More informationInvestigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)
March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for
More informationThis policy applies to research administrators, investigators, research staff, Human Investigation Committee (HIC) members and HIC staff.
REVIEW BY AN EXTERNAL INSTITUTIONAL REVIEW BOARD 233 1 of 5 PURPOSE The purpose of this policy is to establish a procedure for requesting authorization for an approved, external (non-beaumont) institutional
More informationMoving to the Top: Establishing Your Research Program at BWH MODULE 5: Money: How to Spend it January 28, 2010
Moving to the Top: Establishing Your Research Program at BWH MODULE 5: Money: How to Spend it January 28, 2010 Recommended Reading: Chapter 4, Academic Scientists at Work TOPICS: 1) Get to know your research
More informationThe Ontario Cancer Research Ethics Board Overview
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
More informationAdventist HealthCare, Inc.
IRB POLICY ON HUMAN RESEARCH PROTECTION (HRP) AND GOOD CLINICAL PRACTICE (GCP) TRAINING Collaborative Institutional Training Initiative (CITI) Requirements at Adventist Healthcare, Inc. I. Required Human
More informationUniversity of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More informationHollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
More informationRe-engineering Clinical Research Enterprise @ USF Health
Re-engineering Clinical Research Enterprise @ USF Health Presented to: Health Sciences & Research Workgroup Board of Trustees - USF August 17, 2006 Abdul S. Rao, MD, MA, DPhil Senior Associate Vice President
More informationGuidance for Industry
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs & As DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More information2014 Metrics on Human Research Protection Program Performance
2014 Metrics on Human Research Protection Program Performance Updated May 15, 2015 About the Metrics Improving the quality of human research protection programs (HRPP) is a top priority of AAHRPP. Effective
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More informationNova Southeastern University Institutional Review Board Policies and Procedures
Nova Southeastern University Institutional Review Board Policies and Procedures Monitoring of Approved Research, Approval Duration, and Continuing Review Effective 03/08/2007; Revised 10/14/2010; 8/29/2011;
More informationOPERATIONALIZING EXCELLENCE IN THE GLOBAL REGULATORY SUBMISSIONS PROCESS
OPERATIONALIZING EXCELLENCE IN THE GLOBAL REGULATORY SUBMISSIONS PROCESS INTRODUCTION As life sciences companies face expiring patents and shrinking drug-development pipelines, it s never been more important
More informationSharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,
More informationClinical Research Management Webinar Series: Results of Huron s Clinical Trials Management System Survey
Clinical Research Management Webinar Series: Results of Huron s Clinical Trials Management System Survey Wednesday, October 24, 2012 12:00 p.m. - 1:00 p.m. CT About our speakers Rick Rohrbach Managing
More informationJosephine Silvestre, RN, MSN The University of Chicago Medical Center. October 13, 2007
Josephine Silvestre, RN, MSN The University of Chicago Medical Center October 13, 2007 A study in which people participate as volunteers. A clinical trial is conducted to develop potential new treatments
More informationPrincipal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
More informationReliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)
Name of Organization Providing IRB Review: Stony Brook University ( SBU IRB ) Name of Institution Relying on the SBU IRB ( Institution ): Latest AAHRPP Accreditation Date (if applicable) OHRP Federal Wide
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationOffice of Clinical Research (OCR)
Office of Clinical Research (OCR) Your Partner in the Clinical Research Process h3p://bsdocr.bsd.uchicago.edu Phone: 834-1238 Susan L. Cohn, MD Dean for Clinical Research Professor of Pediatrics OCR Created
More informationWhite Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION
White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION Table of Contents 1. Healthcare Landscape in Poland... 3 2. Clinical Research Activity in Poland... 3 3. References... 6 4. About the Author... 6
More informationAcademic Health Center Six-Year Strategic Plan October 20, 2000
Goal 1: Create and Prepare the New Health Professionals for Minnesota Strategic Objectives 1.0 Develop and implement interdisciplinary health professional education opportunities that: Emphasize the core
More informationIntroduction to Clinical Research
Introduction to Clinical Research NCURA Region I Spring Meeting May 5, 2015 Agenda Introductions Brief History of Clinical Research Clinical Research in Context Clinical Research Compliance Clinical Research
More informationBreast Cancer Registry of Greater Cincinnati (BCRGC) APPLICATION for ACCESS to INFORMATION/DATA
Breast Cancer Registry of Greater Cincinnati (BCRGC) APPLICATION for ACCESS to INFORMATION/DATA Application Date: / / 20 Applicant's Name: LAST FIRST MIDDLE INITIAL Study Title: Institutional Affiliation(s)
More informationMaking Ontario a Preferred Location for Global Clinical Trials
Making Ontario a Preferred Location for Global Clinical Trials Clinical Trials Ontario Inaugural Strategic Plan 2012 2017 Strategic Plan Table of Contents LIST OF ABBREVIATIONS... 3 EXECUTIVE SUMMARY...
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More informationWhat We Are..! www.ardent-cro.com
Your Trusted CRO! Regus, Level-2, Connaught Place, Bund Garden Road, Pune-411001, MH, India. Phone: 020-65-31-31-71 Email: ardent@ardent-cro.com Web: What We Are..! Ardent Clinical Research Services is
More informationBUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE Jean Toth-Allen, Ph.D. Biophysicist Office of Good Clinical Practice Office of the Commissioner May 14, 2012 1 Overview I. Background why we are
More information12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
More informationEthics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationComparison of Clinical Trials Registry Legislation in the Senate and House Prepared by Tannaz Rasouli, AAMC Office of Governmental Relations
Comparison of Clinical Trials Registry Legislation in the Senate and House Prepared by Tannaz Rasouli, AAMC Office of Governmental Relations Clinical Trials Registry S. 1082 (Title II, Subtitle C) H.R.
More informationUMDNJ COMPLIANCE PLAN
UMDNJ COMPLIANCE PLAN INTRODUCTION...2 COMPLIANCE OVERSIGHT 3 COMPLIANCE COMMITTEE STRUCTURE...4 CHIEF COMPLIANCE OFFICER S RESPONSIBILITIES...5 RESEARCH COMPLIANCE.5 UNIT IMPLEMENTATION.6 COMPLIANCE POLICIES
More informationCLINICAL RESEARCH GENERIC TASK DESCRIPTIONS
Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within
More informationRoles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
More informationHistory and Principles of Good Clinical Practice
History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices
More informationRutgers - UMDNJ Integration: The Path Forward from Good to Great and The Role of Responsibility Center Management (RCM)
Rutgers - UMDNJ Integration: The Path Forward from Good to Great and The Role of Responsibility Center Management (RCM) Terri Goss Kinzy, Ph.D., Associate Vice President for Research Kathleen Bramwell,
More informationClinical Trial Protocol Development. Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group
Clinical Trial Protocol Development Developed by Center for Cancer Research, National Cancer Institute Endorsed by the CTN SIG Leadership Group Objectives The clinical trial protocol is the heart of any
More informationYale Cancer Center Data and Safety Monitoring Committee Charter
Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety
More informationAttachment B HIPAA-P03 Instructions for Completing IU s Authorization for Research Purposes
Attachment B HIPAA-P03 Instructions for Completing IU s Authorization for Research Purposes The HIPAA Privacy Rule generally prohibits health care providers from using or releasing protected health information
More informationOffice of Research Administration: Clinical Research Contracting
Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Presented by: Patricia Travis and Mont Brownlee October 22, 2013 1 Training Agenda
More informationAURA Meeting 05/28/2014
AURA Meeting 05/28/2014 Welcome Karen Niemeier Contracts Director, OSP Website Spotlight Cherrelle Duncan, MPSA Assigning a Delegate Sometimes, faculty members are unavailable. Delegates can be assigned
More informationDecember 13, 2011 Maureen Coyne
December 13, 2011 Maureen Coyne No industry relationships No financial conflicts of interests Recent experience weighted toward industrysponsored clinical trials Information based on my experiences IRB
More informationExpanded Access Programs. Richard Klein Office of Special Health issues Food and Drug Administration
Expanded Access Programs Richard Klein Office of Special Health issues Food and Drug Administration Expanded Access Programs (EAPs) What is expanded access? History Legislative background General principles
More informationHow To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
More informationNebraska Department of Health and Human Services Research Policy
Nebraska Department of Health and Human Services Research Policy I. PURPOSE The purpose of the Nebraska Department of Health and Human Services (DHHS) Research Policy is: a) to provide a process for the
More informationA Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
More informationMedical Billing Human Research Studies Seminar Notes
Audits If a department learns that an external audit is going to be initiated, the Billing Compliance Department and Research Administration should be notified when the scope of the audit involves billing
More informationOnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry
OnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry OnCore CTMS Registration Requirements Main Tab Institution Tab Reviews Tab Status Tab Accrual Tab Version
More informationPediatric Trials Network. Danny Benjamin MD PhD Professor of Pediatrics Duke University www.dcri.org/about-us/conflict-of-interest
Pediatric Trials Network Danny Benjamin MD PhD Professor of Pediatrics Duke University www.dcri.org/about-us/conflict-of-interest Pediatric Drug Development 1998: essentially no trials Mandate (Pediatric
More informationTHE FEDERAL DEMONSTRATION PARTNERSHIP February 4, 2002 SOLICITATION TO PARTICIPATE IN PHASE IV
THE FEDERAL DEMONSTRATION PARTNERSHIP February 4, 2002 SOLICITATION TO PARTICIPATE IN PHASE IV [NOTE: THIS IS A REVISED EDITION OF THE FEBRUARY 4, 2002 SOLICITATION WITH ADDITIONAL AND UPDATED INFORMATION
More informationGuidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.
Guidance for Sponsors, Investigators, and Institutional Review Boards Questions and Answers on Informed Consent Elements, 21 CFR 50.25(c) (Small Entity Compliance Guide) U.S. Department of Health and Human
More informationRecords and Clinical Trials
Integrating Electronic Health Records and Clinical Trials The Children s Hospital An Examination of Pragmatic Issues Affiliated with University of Colorado Health Sciences Center Denver, Colorado Michael
More informationCLINICAL DEVELOPMENT OPTIMIZATION
PAREXEL CLINICAL RESEARCH SERVICES CLINICAL DEVELOPMENT OPTIMIZATION Enhancing the clinical development process to achieve optimal results ADVANCED TECHNOLOGY COMBINED WITH INTELLIGENT THINKING CAN HELP
More informationThe Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
More informationResearch Administration at the University of Maryland
Research Administration at the University of Maryland Anne S. Geronimo, M.S. Director, Research Development Division of Research University of Maryland June 2007 Tokyo, Japan University of Maryland Profile
More informationCore Training Outline
Core Training Outline Modules: 1) Study Design 2) PI Oversight 3) Financial Management 4) Study Operations 5) Recruitment & Retention 6) Informed Consent 7) Investigational Products 8) Subject Safety 9)
More informationUPDATE ON THE CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) PROGRAM
UPDATE ON THE CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) PROGRAM Todd Wilson, D.O. Medical Officer Division of Clinical Innovation National Center for Advancing Translational Sciences Clinical and
More informationUse of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009
Use of Electronic Health Records in Clinical Research: Core Research Data Element Exchange Detailed Use Case April 23 rd, 2009 Table of Contents 1.0 Preface...4 2.0 Introduction and Scope...6 3.0 Use Case
More informationExtemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
More informationUniversity of Utah College of Nursing
1 of 5 University of Utah College of Nursing Overview All research conducted in the Intermountain Healthcare Simulation Learning Center (SLC) must receive approval from the SLC Advisory Committee. The
More informationINSURANCE & RISK MANAGEMENT
INSURANCE & RISK MANAGEMENT For Global Human Clinical Trials By Daniel Brettler Senior Vice President, Conner Strong & Buckelew I. GENERAL OVERVIEW Often overlooked in the early planning of a human clinical
More informationSupporting Clinical Research
Supporting Clinical Research AAAS/Science Translational Medicine Panel Library-based Support for Translational Medicine Jennifer A. Lyon, MS, MLIS, AHIP Clinical Research Librarian UF Health Science Center
More informationMayo Alliance for Clinical Trials
Mayo Alliance for Clinical Trials A Division within Mayo Clinical Trial Services PROFESSIONAL CLINICAL TRIALS SERVICES ADVANCING PATIENT CARE THROUGH SCIENTIFIC DISCOVERY It is a great thing to make scientific
More informationSignature Requirements for the etmf
Wingspan Technology Signature Requirements for the etmf A Regulatory and Technological Assessment Kathie Clark Director, Product Management Wingspan Technology 1 November 2012 Signature Requirements for
More informationNova Southeastern University IRB - Consent Form Checklist Version Date: 02/17/2010
Nova Southeastern University IRB - Consent Form Checklist Version Date: 02/17/2010 This form is intended to assist researchers in creating consent and assent forms. Informed consent is one of the primary
More informationMASTER AGREEMENTS How to use them to advance academic and corporate interests
MASTER AGREEMENTS How to use them to advance academic and corporate interests March 30-31, 2015 Purdue University Purdue Memorial Hall West Lafayette, IN The University Industry Demonstration Partnership
More information2/25/2014. HRPP Compliance Institutional Review Board Regulatory Affairs Conflict of Interest
Site Based Clinical Research at Duke Mark Stacy, MD Professor of Neurology Vice Dean for Clinical Research Duke University School of Medicine Clinical Research Success: 2013 ClinicalTrials.gov RDSP compliance
More information